FAPI and FDG scans for bladder cancer
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial is testing if two types of PET/MRI scans (one using FAPI tracer, another using FDG tracer) are better at finding and evaluating muscle-invasive bladder cancer. It may help doctors decide the best treatment for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have or are suspected to have muscle-invasive bladder cancer.
- You are willing to have two special PET/MRI scans (one with FAPI, one with FDG) and a regular MRI.
- You have not had any other type of cancer.
- You do not have serious heart, lung, liver, or kidney disease.
- You are not allergic to the contrast dye used in scans.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study uses special MRI imaging to create a “virtual view” of the bladder wall so doctors can better stage bladder cancer before treatment. If you qualify, you may get MRI imaging using contrast medicines as part of planning your surgery.
This trial tests a new imaging agent called 68Ga-FAPI to see how well it finds rectal cancer and guides treatment. It's for people with new stage II or III rectal cancer who are about to start neoadjuvant therapy (treatment before surgery).
This Phase 2 study checks whether an FDG PET-CT scan can help doctors better predict bladder cancer risk and adjust treatment. You may still get standard bladder cancer care, but the study uses the scan results to help decide how aggressive treatment should be.
This trial tests a new imaging method (FAPI PET) along with a liquid biopsy to better understand how far bladder cancer has spread and to guide treatment decisions.
This study uses a special PET/CT scan to see how far your bladder cancer has spread. The results may help doctors plan the best treatment for you.
This trial tests a new imaging method (FAPI PET/MRI) to see if it can help evaluate breast cancer. It focuses on people with invasive breast cancer who are about to start treatment before surgery or who have recurrent or new breast cancer.
Hear when a new Urinary Bladder Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.